Search

Search bills, members, committees and pages...

H 168

Massachusetts HouseIntroduced

Summary

H 168, “Requiring the Cannabis Control Commission to regulate intoxicating hemp products”, was introduced in the House on Feb 27, 2025 by Rep. Dawne Shand (D). It last saw action on May 29, 2025: Accompanied a new draft, see H4160.


Record

Text

H 168 has no co-sponsors and has not gone to a roll call.

h168/introduced.txt
HOUSE DOCKET, NO. 1998 FILED ON: 1/15/2025
HOUSE . . . . . . . . . . . . . . . No. 168
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Dawne Shand
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act requiring the Cannabis Control Commission to regulate intoxicating hemp products.
_______________
PETITION OF:
NAME: DISTRICT/ADDRESS: DATE ADDED:
Dawne Shand 1st Essex 1/15/2025
1 of 1
HOUSE DOCKET, NO. 1998 FILED ON: 1/15/2025
HOUSE . . . . . . . . . . . . . . . No. 168
By Representative Shand of Newburyport, a petition (accompanied by bill, House, No. 168) of
Dawne Shand relative to requiring the Cannabis Control Commission to regulate intoxicating
hemp products. Cannabis Policy.
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Fourth General Court
(2025-2026)
_______________
An Act requiring the Cannabis Control Commission to regulate intoxicating hemp products.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
of the same, as follows:
Section XX. Chapter 94G, as so appearing, is hereby further amended by adding the
following sections:-
Section 23. (a) As used in sections 23-24, the following words shall, unless the context
clearly requires otherwise, have the following meanings:-
“Artificially derived”, the creation of a chemical substance by a chemical reaction that
changes the molecular structure of any chemical substance.
“Cannabidiol (CBD)” means a nonpsychoactive cannabinoid found in the cannabis sativa
plant. CBD has the formula C21H30O2 and chemical structure, inclusive of stereochemical
variations. CBD is not tetrahydrocannabinol.
“Cannabinoids” means compounds structurally defined as a diverse class of C21 or C22
terpenophenolic compounds found in Cannabis sativa L., their carboxylic acids, analogs, and
1 of 4
transformation products. Cannabinoids, for the purposes of this chapter, shall include structurally
unrelated cannabimimetic compounds. The main cannabinoids found in cannabis plants are
Tetrahydrocannabinol (THC) and Cannabidiol (CBD). In addition to THC and CBD, there are
more than 100 cannabinoids that could be identified.
“Cannabimimetic”, a compound that is not structurally a cannabinoid, but which can
elicit a biological response similar to those produced by cannabinoids by acting directly or
indirectly on cannabinoid receptors in the body.
“Delta-8-tetrahydrocannabinol (Delta-8-THC)”, a psychoactive cannabinoid compound
found in the Cannabis sativa plant, but does not occur in naturally significant amounts. It has the
chemical formula C21H30O2 and the chemical structure inclusive of stereochemical variations.
“Delta-9-tetrahydrocannabinol (Delta-9-THC)”, a psychoactive cannabinoid compound
found in the Cannabis sativa plant, and the primary psychoactive compound found in marijuana.
Delta-9 THC has the formula C21H30O2 and the chemical structure inclusive of stereochemical
variations.
“Dry weight basis”, a method of determining the percentage of a chemical in a substance
after removing the moisture from the substance. The ratio of the amount of moisture in a sample
to the amount of dry solid in a sample.
“Decarboxylation”, a process of treating a cannabis material or product to remove
carboxyl groups from the cannabinoids native in the plant, to form transformation products such
as THC and CBD. Decarboxylation is commonly accomplished by application of heat.
Decarboxylation is not considered a synthetic process.
2 of 4
“Hemp-derived cannabinoid product”, a product derived from hemp intended for human
consumption, by means including, but not limited to ingestion, injection or inhalation, that
contains more than .5 milligrams of total tetrahydrocannabinol (THC) per any serving or other
individual unit, and 2.5 milligrams per multi-serving package, container, or packages or
containers sold as a single unit.
“Intoxicating tetrahydrocannabinols”, naturally occurring, synthetically derived,
artificially derived, isomerized, or synthetically converted tetrahydrocannabinols which, when
consumed, have the potential to induce disturbances in nervous system function and may result
in changes in cognition, perception, judgement, mood, consciousness, or behavior, that resolve
with time.
“Isomers”, molecules or polyatomic ions with identical molecular formulae (i.e., the
same number of atoms of each element) but distinct arrangements of atoms in space.
“Isomerization”, is the process in which a molecule, polyatomic ion or molecular
fragment is transformed into an isomer with a different chemical structure.
“Tetrahydrocannabinol (THC)”, (i) all naturally, synthetically or artificially derived
tetrahydrocannabinols, or any structural, optical or geometric isomers or analogs of
tetrahydrocannabinols, which include but are not limited to, Delta-1 tetrahydrocannabinol; Delta-
6 tetrahydrocannabinol; Delta 3,4 tetrahydrocannabinol; Delta-8 tetrahydrocannabinol; Delta-9
tetrahydrocannabinol; Delta-10 tetrahydrocannabinol, Delta-11 tetrahydrocannabinol; (ii) any
other intoxicating tetrahydrocannabinols, (iii) any other naturally or artificially derived
cannabinoid that has an intoxicating or psychoactive effect; and (iv) any other chemically similar
compound, substance, derivative, or isomer of tetrahydrocannabinol.
3 of 4
“Tetrahydrocannabiolic acid (THCA)”, a naturally occurring cannabinoid compound
found in the cannabis sativa plant. THCA is the precursor to THC through decarboxylation.
THCA has the chemical formula C22H30O4.
(b) No person may engage in the sale or transfer of hemp-derived cannabinoid products
or Tetrahydrocannabiolic acid (THCA) without receiving an intoxicating hemp endorsement
from the commission. The commission shall impose and collect fees pursuant to section 4 for
intoxicating hemp endorsements.
(c) All THC, CBD, hemp and hemp derived cannabinoids shall be tested by an
independent testing laboratory licensed by the commission prior to any sale or transfer to another
person, consumer or patient within the commonwealth.
(d) The commission shall issue rules and promulgate or amend regulations necessary to
implement this section.
(e) This section shall not be construed to prevent the cultivation and production of hemp
pursuant to sections 116-123 of chapter 128 of the General Laws, or to prevent the interstate
transportation of hemp or hemp-derived products in compliance with federal law.
Section 24. Whoever violates section 23(b) shall be punished by imprisonment for not
more than 1 year in the house of correction or by a fine of not more than $25,000 per day, or by
both such fine and imprisonment.
4 of 4

Relative to requiring the Cannabis Control Commission to regulate intoxicating hemp products. Cannabis Policy.

Sponsors

Rep. Dawne Shand (D) sponsors H 168 alone.

Committees

H 168 went before 1 committee: Cannabis Policy.

Cannabis Policy
Cannabis Policy
Referred to · Feb 27, 2025

History

H 168 has taken 4 actions since Feb 27, 2025, the latest on May 29, 2025.

ChamberAction
May 29, 2025
House
Accompanied a new draft, see H4160
May 1, 2025
J
Hearing scheduled for 05/07/2025 from 10:30 AM-01:00 PM in B-1
Feb 27, 2025
House
Referred to the Joint Committee on Cannabis Policy
Feb 27, 2025
Senate
Senate concurred

Votes

H 168 has not gone to a roll call.


Source: malegislature.gov · legiscan.com